VolitionRx Limited
VNRX
$0.31
$0.001.26%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.47M | 1.32M | 1.31M | 1.23M | 1.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.47M | 1.32M | 1.31M | 1.23M | 1.29M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.47M | 1.32M | 1.31M | 1.23M | 1.29M |
| SG&A Expenses | 13.97M | 13.40M | 13.09M | 13.85M | 14.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.17M | 24.79M | 25.47M | 28.26M | 31.27M |
| Operating Income | -22.70M | -23.47M | -24.16M | -27.02M | -29.98M |
| Income Before Tax | -23.06M | -23.52M | -24.26M | -27.26M | -30.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.06 | -23.52 | -24.26 | -27.26 | -30.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 178.20K | 193.80K | 238.40K | 290.10K | 327.70K |
| Net Income | -22.88M | -23.32M | -24.02M | -26.97M | -29.87M |
| EBIT | -22.70M | -23.47M | -24.16M | -27.02M | -29.98M |
| EBITDA | -21.65M | -22.38M | -23.06M | -25.91M | -28.87M |
| EPS Basic | -0.23 | -0.25 | -0.27 | -0.31 | -0.36 |
| Normalized Basic EPS | -0.14 | -0.15 | -0.17 | -0.20 | -0.22 |
| EPS Diluted | -0.23 | -0.25 | -0.27 | -0.31 | -0.36 |
| Normalized Diluted EPS | -0.14 | -0.15 | -0.17 | -0.20 | -0.22 |
| Average Basic Shares Outstanding | 401.03M | 380.70M | 360.72M | 346.14M | 331.97M |
| Average Diluted Shares Outstanding | 401.03M | 380.70M | 360.72M | 346.14M | 331.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |